SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-118164
Filing Date
2024-04-26
Accepted
2024-04-26 16:30:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d784952ddefa14a.htm DEFA14A 10053
2 GRAPHIC g784952g02g02.jpg GRAPHIC 193639
3 GRAPHIC g784952g03g03.jpg GRAPHIC 126124
  Complete submission text file 0001193125-24-118164.txt   451554
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40287 | Film No.: 24884376
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)